Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gut lymphomas

E Zucca1, F Cavalli

  • 1Servizio Oncologico, Ospedale San Giovanni, Bellinzona, Switzerland.

Bailliere'S Clinical Haematology
|December 1, 1996
PubMed
Summary
This summary is machine-generated.

Gut lymphomas require updated classification and treatment strategies. Combination chemotherapy is preferred for aggressive cases, while localized MALT lymphomas may benefit from H. pylori eradication, potentially avoiding surgery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic heterogeneity-based radiomic model predicts treatment outcomes of primary mediastinal B-cell lymphoma patients in the IELSG37 study.

British journal of haematology·2026
Same author

Left and right-side echocardiographic measurement of pulmonary artery stiffness in thoroughbred racehorses.

Journal of equine veterinary science·2026
Same author

Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Primary central nervous system lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma.

Blood·2023
Same author

Corrigendum to "Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 31 (2020) 17-29].

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same journal

Current status of stem cell therapy and prospects for gene therapy for the disorders of globin synthesis.

Bailliere's clinical haematology·2000
Same journal

Pharmacological therapy.

Bailliere's clinical haematology·2000
Same journal

Prenatal diagnosis and screening of the haemoglobinopathies.

Bailliere's clinical haematology·2000
Same journal

Sickle cell disease: clinical management.

Bailliere's clinical haematology·2000
Same journal

Pathophysiology of sickle cell disease.

Bailliere's clinical haematology·2000
Same journal

Thalassaemia: clinical management.

Bailliere's clinical haematology·2000
See all related articles

Area of Science:

  • Gastroenterology
  • Oncology
  • Pathology

Background:

  • Gut lymphomas present challenges in classification, staging, and treatment due to retrospective studies and evolving diagnostic criteria.
  • Historical classifications predated the recognition of Mucosa-Associated Lymphoid Tissue (MALT) lymphomas as a distinct entity originating in gastrointestinal mucosa.

Purpose of the Study:

  • To advocate for modern histological criteria for primary gastrointestinal lymphomas.
  • To recommend the adoption of the 1988 Isaacson et al. classification, aligning with Kiel Classification principles and incorporating MALT lymphomas.
  • To review current treatment strategies for gut lymphomas, considering chemotherapy and surgical interventions.

Main Methods:

  • Review of existing literature and historical studies on gut lymphomas.

Related Experiment Videos

  • Analysis of pathological classification systems, including the Kiel Classification and the Isaacson et al. system.
  • Evaluation of treatment outcomes for combination chemotherapy versus primary surgery in various gut lymphoma subtypes.

    • Main Results:

    • Combination chemotherapy is the primary treatment for aggressive gut lymphomas with advanced disease.
    • Surgery's role is being re-evaluated, potentially shifting towards salvage therapy for gastric lymphomas after conservative treatment failure.
    • Localized, low-grade gastric MALT lymphomas may be managed conservatively with H. pylori eradication, possibly obviating surgery.

    Conclusions:

    • Adoption of standardized, modern histological criteria is crucial for consistent gut lymphoma classification.
    • Treatment approaches should be tailored to lymphoma subtype and stage, with chemotherapy favored for aggressive disease and conservative measures considered for indolent MALT lymphomas.
    • Further research is needed to definitively establish the role of surgery in primary intestinal lymphoma.